Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Monocyte distribution width (MDW) in sepsis.
Agnello L, Ciaccio AM, Vidali M, Cortegiani A, Biundo G, Gambino CM, Scazzone C, Lo Sasso B, Ciaccio M. Agnello L, et al. Among authors: biundo g. Clin Chim Acta. 2023 Aug 1;548:117511. doi: 10.1016/j.cca.2023.117511. Epub 2023 Aug 9. Clin Chim Acta. 2023. PMID: 37562521 Review.
Time-dependent stability of monocyte distribution width (MDW).
Agnello L, Giglio RV, Gambino CM, Iacona A, Mancuso G, Biundo G, Lo Sasso B, Vidali M, Ciaccio M. Agnello L, et al. Among authors: biundo g. Clin Chim Acta. 2022 Aug 1;533:40-41. doi: 10.1016/j.cca.2022.06.013. Epub 2022 Jun 14. Clin Chim Acta. 2022. PMID: 35714937 No abstract available.
Clinical usefulness of presepsin and monocyte distribution width (MDW) kinetic for predicting mortality in critically ill patients in intensive care unit.
Agnello L, Ciaccio AM, Ben FD, Gambino CM, Scazzone C, Giglia A, Biundo G, Cortegiani A, Sasso BL, Ciaccio M. Agnello L, et al. Among authors: biundo g. Front Med (Lausanne). 2024 May 20;11:1393843. doi: 10.3389/fmed.2024.1393843. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38831992 Free PMC article.
Difference in safety and humoral response to mRNA SARS-CoV-2 vaccines in patients with autoimmune neurological disorders: the ANCOVAX study.
Giannoccaro MP, Vacchiano V, Leone M, Camilli F, Zenesini C, Panzera I, Balboni A, Tappatà M, Borghi A, Salvi F, Lugaresi A, Rinaldi R, Di Felice G, Lodi V, Lazzarotto T, Liguori R; ANCOVAX study group. Giannoccaro MP, et al. J Neurol. 2022 Aug;269(8):4000-4012. doi: 10.1007/s00415-022-11142-7. Epub 2022 May 3. J Neurol. 2022. PMID: 35503375 Free PMC article.